World Malaria Day 2025: Emzor’s Commitment to a Malaria-Free Nigeria and Africa
Emzor Pharmaceutical Industries, a number one title in Nigeria’s pharmaceutical sector, proudly joins the world community in commemorating World Malaria Day 2025.
The corporate reaffirms its unwavering commitment to supporting both national and world efforts aimed toward combating the high prevalence of malaria in Nigeria and all over Sub-Saharan Africa.
This one year’s theme, “Malaria Ends With Us: Reinvest, Reimagine, Reignite,” closely aligns with Emzor’s vision of making a tangible impact within the world wrestle in opposition to malaria.
For years, Emzor has been at the forefront of malaria prevention and cure—producing high quality antimalarial medicines which will most doubtless be both accessible and cheap for millions all over Africa, acknowledged Kunle Faloye, Head of Advertising and marketing and marketing and Technique, at Emzor Pharmaceutical Industries.
Our dedication is reflected in our funding in study, pattern, and big-reaching distribution networks, which beget played a compulsory role in reducing the malaria burden, persevered Faloye.
To mark World Malaria Day 2025, Emzor organised a series of impactful community outreach activities, including a health race, free clinical screenings, and the distribution of antimalarial medicine to vulnerable populations.
Malaria is still a number one motive for death amongst pregnant women and youngsters under five in Africa. Emzor’s prolonged-standing initiatives in malaria reduction an eye on consist of the manufacturing of well-known antimalarial medicine aimed toward reducing maternal and child mortality rates.
Emzor currently produces over 20 antimalarial SKUs which consist of Maldox Sulfadoxine/Pyrimethamine), Lokmal (Artemether/Lumefantrine), Piramal TS (Dihydroartemisinin/Piperaquine), Diasunate (Artesunate/Amodiaquine), and Chloroquine, in completely different dosage kinds including medicines, suspensions and dispersible medicines.
Extra underscoring this commitment is Emzor’s multimillion-dollar funding within the gather of Active Pharmaceutical System (API), within the in fashion manufacturing Pharmaceutical Campus positioned in Sagamu, Ogun Narrate. The plant will first and most most essential focal point on the manufacturing of antimalarial APIs (namely Arthemeter, Lumefantrine, Sulfadoxine and Pyrimethamine). The chosen APIs provide the WHO-recommended cure of malaria for adults and youngsters, to boot to the chemo-preventive aggregate therapies for malaria in both pregnant women and youngsters under five.
This strategic funding boosts Nigeria’s capability to within the community produce a huge differ of antimalarial medicine, thereby bettering gather entry to to top of the range remedies all over sub-Saharan Africa. The venture further underscores Emzor’s prolonged-standing commitment to strengthening the pharmaceutical sector within the distance.
The venture’s particular impact will cut Nigeria’s dependence on imports from Asia, give a enhance to GDP grunt and cut the quiz of foreign alternate, and cut the price of manufacturing and gather entry to to those existence-saving medicines by the people that need them most.
With roughly 95% of all malaria situations and 96% of the deaths taking place on the continent, that is predominantly an African misfortune and as a consequence of this truth, the alternatives have to soundless also largely advance from the continent.
At Emzor, we’re taking part in our share, and pioneering the API venture on the continent indubitably fits into this, acknowledged Emeka Okoli, Chairman of the Board of Directors of Emzor Pharmaceutical Industries.
Emzor also works in partnership with native governments, NGOs, and communities to place into effect grassroots outreach programmes thinking about training, prevention, prognosis, and cure.
The corporate continues to present subsidized and free medicines to pregnant women and youngsters, the teams most liable to malaria.
As we mark this most essential day, Emzor stays steadfast in our resolve to make a contribution to world efforts toward malaria eradication. We are in a position to continue to innovate, collaborate, and spend money on sustainable healthcare alternatives that toughen lives all over Nigeria and the continent, added Faloye.
About Emzor Pharmaceutical Industries
Emzor Pharmaceutical Industries is one amongst the leading Nigerian pharmaceutical corporations dedicated to the study, pattern, manufacturing, and distribution of high quality and cheap healthcare merchandise and products and companies.
With a highlight on antimalarial medicine as a precedence home in accordance with the United Nations Sustainable Pattern Targets, Emzor has established itself as a key player within the wrestle in opposition to malaria in Nigeria and Africa.
With a solid commitment to corporate social accountability, Emzor supports initiatives that promote training and economic empowerment for women and vulnerable populations.
Sponsored Grunt
